Secondary Logo

Journal Logo

You can read the full text of this article if you:

Access through Ovid
Original Articles

Body composition and bone mineral density after ovarian hormone suppression with or without estradiol treatment

Shea, Karen L. MD1; Gavin, Kathleen M. PhD1; Melanson, Edward L. PhD1,2; Gibbons, Ellie BS1; Stavros, Anne BS1; Wolfe, Pamela MS3; Kittelson, John M. PhD3; Vondracek, Sheryl F. PharmD4; Schwartz, Robert S. MD1; Wierman, Margaret E. MD2; Kohrt, Wendy M. PhD1

Author Information
doi: 10.1097/GME.0000000000000430

Abstract

Erratum

In the article appearing in volume 22, pages 1045-1052 of Menopause, entitled “Body composition and bone mineral density after ovarian hormone suppression with or without estradiol treatment,” there was an error.

On page 1047, the text under Methods section is incorrect. The correct text is as follows:

Blood samples for sex hormones were collected during baseline testing and on week 20 of the intervention. Collection samples were stored at −80°C until analysis. Estrone (E1) was determined by radioimmunoassay (Diagnostic Systems Laboratory, Webster, TX) with intra-assay and inter-assay coefficients of variation of 8.7% and 8.6%. E2 (4.3% and 8.2%), progesterone (4.4% and 7.9%), sex hormone-binding globulin (SHBG; 3.6% and 5.7%) and total testosterone (2.1% and 5.1%) were analyzed by chemiluminescence immunoassay (Access 2 Immunoassay System Analyzer, Beckman Coulter Inc, Fullerton, CA).

This has been corrected in the online version of the article.

Menopause. 25(3):359, March 2018.

© 2015 by The North American Menopause Society.